Subcortical and medial temporal MR-detectable metabolite abnormalities in unipolar major depression

  • Gabriele Ende
  • , Traute Demirakca
  • , Sigrid Walter
  • , Tim Wokrina
  • , Alexander Sartorius
  • , Dirk Wildgruber
  • , Fritz A. Henn

Research output: Contribution to journalArticlepeer-review

13 Scopus citations

Abstract

The purpose of the present study was to determine whether MR-detectable alterations of choline-containing compounds in two key neural systems involved in major depression disorder namely the hippocampus and the basal ganglia can be detected. Multislice proton magnetic resonance spectroscopic imaging was applied in 11 patients with major depressive disorder (MDD) and ten matched healthy subjects. Voxels were selected from the left and right side of the hippocampus and the putamen. Significantly lower choline-containing compounds in the hippocampus and significantly higher choline-containing compounds in the putamen of patients with MDD compared to healthy subjects were found. No significant differences were found for the other metabolites in the two regions evaluated. Abnormal levels of choline-containing compounds most likely reflect altered membrane phospholipid metabolism. A reduced level in the hippocampus and an increased level in the putamen suggest regionally opponent membrane abnormalities.

Original languageEnglish
Pages (from-to)36-39
Number of pages4
JournalEuropean Archives of Psychiatry and Clinical Neuroscience
Volume257
Issue number1
DOIs
StatePublished - Feb 2007
Externally publishedYes

Keywords

  • Choline-containing compounds
  • Hippocampus
  • MR spectroscopic imaging
  • Major depressive disorder
  • Putamen

Fingerprint

Dive into the research topics of 'Subcortical and medial temporal MR-detectable metabolite abnormalities in unipolar major depression'. Together they form a unique fingerprint.

Cite this